Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen and buprenorphine for acute pain
NCT04251819Phase 3Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Jan 2021
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of baclofen in acute pain, sponsored by University of Alabama at Birmingham. Primary endpoint: Pain Threshold at 1 week. Started Jan 2021; status: terminated.
02
Drugs
baclofen
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04251819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04251819.